<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-10T15:53:35Z</responseDate>
  <request identifier="oai:figshare.com:article/33957532" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33957532</identifier>
        <datestamp>2026-09-21T17:43:48Z</datestamp>
        <setSpec>category_12</setSpec>
        <setSpec>category_16</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_122</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Dataset.&lt;/p&gt;</dc:title>
          <dc:creator>Toshio Narimatsu (25073328)</dc:creator>
          <dc:creator>Noriko Onozato (25084822)</dc:creator>
          <dc:creator>Haruna Togawa (25084825)</dc:creator>
          <dc:creator>Shigeto Shimmura (227780)</dc:creator>
          <dc:creator>Yoko Ozawa (418834)</dc:creator>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Physiology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Mental Health</dc:subject>
          <dc:subject>xlink "&gt; increase</dc:subject>
          <dc:subject>social issue worldwide</dc:subject>
          <dc:subject>measured using grey</dc:subject>
          <dc:subject>uncorrected visual acuity</dc:subject>
          <dc:subject>corrected visual acuity</dc:subject>
          <dc:subject>contrast visual acuity</dc:subject>
          <dc:subject>729 &amp;# 8211</dc:subject>
          <dc:subject>293 &amp;# 8211</dc:subject>
          <dc:subject>255 &amp;# 8211</dc:subject>
          <dc:subject>186 &amp;# 8211</dc:subject>
          <dc:subject>079 &amp;# 8211</dc:subject>
          <dc:subject>040 &amp;# 8211</dc:subject>
          <dc:subject>2 %) males</dc:subject>
          <dc:subject>less myopic eyes</dc:subject>
          <dc:subject>43 healthy eyes</dc:subject>
          <dc:subject>general bcva 0</dc:subject>
          <dc:subject>visual ability</dc:subject>
          <dc:subject>&amp;# 8722</dc:subject>
          <dc:subject>myopic eyes</dc:subject>
          <dc:subject>healthy adults</dc:subject>
          <dc:subject>without histories</dc:subject>
          <dc:subject>scale optotypes</dc:subject>
          <dc:subject>retrospectively analyzed</dc:subject>
          <dc:subject>ocular diseases</dc:subject>
          <dc:subject>normal best</dc:subject>
          <dc:subject>mean low</dc:subject>
          <dc:subject>exhibits differences</dc:subject>
          <dc:subject>confidence interval</dc:subject>
          <dc:subject>best correction</dc:subject>
          <dc:subject>axial length</dc:subject>
          <dc:subject>43 participants</dc:subject>
          <dc:subject>07 years</dc:subject>
          <dc:subject>039 ).</dc:subject>
          <dc:subject>008 ),</dc:subject>
          <dc:subject>001 ).</dc:subject>
          <dc:description>&lt;div&gt;&lt;p&gt;Increase in myopia is a social issue worldwide. However, whether non-pathologic myopia with normal best-corrected visual acuity (BCVA) exhibits differences in visual ability is not well-documented. Data of 43 healthy eyes in 43 participants (52.8 ± 6.07 years) including 13 (30.2%) males who underwent eye medical checkups at Fujita Medical Innovation Center, Tokyo were retrospectively analyzed. Eyes with general BCVA 0 in logMAR or better and without histories of ocular diseases and surgeries were included. Mean low-contrast visual acuity (LCVA) measured using grey-scale optotypes with best correction was 0.17 ± 0.13 (range, −0.079–0.53; median, 0.15). LCVA was correlated with age (r = 0.2634, 95% confidence interval [CI] −0.040–0.522, P = 0.039). Eyes with LCVA better than 0.15 was associated with uncorrected visual acuity (OR, 43.425; 95%CI, 3.729–1250.027; P = 0.010), subjective spherical equivalent (OR, 1.761; 95%CI, 1.255–2.776; P = 0.004), subjective spherical power (OR, 1.616; 95%CI, 1.186–2.433; P = 0.008), and axial length (OR, 0.550; 95%CI, 0.293–0.951; P = 0.032) after adjusted for age and sex. Mean LCVA of less myopic eyes with spherical equivalent &gt; −3.0 diopters was 0.12 ± 0.10 (median, 0.10), and that of more myopic eyes was 0.23 ± 0.14 (median, 0.22) (P &lt; 0.001). Non-pathological myopic eyes exhibited worse LCVA under best correction and had a risk of worse visual ability.&lt;/p&gt;&lt;/div&gt;</dc:description>
          <dc:date>2026-09-21T17:43:46Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0357713.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Dataset_p_/33957532</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
